Star Biopharma Consulting

What Star Biopharma Consulting does

Star Biopharma Consulting (SBC) is a privately held life sciences consulting firm headquartered in Malvern, Pennsylvania (operating as Star Biopharma Consulting LLC), serving pharmaceutical, biotechnology, and medical device clients. The firm delivers six integrated service lines: Scientific Communications and Publications, Real World Evidence and Data Solutions, Medical Affairs, Patient-Centered Research, Market Access Support, and Staffing and Recruitment. Its core focus is planning, executing, and communicating real-world evidence studies that support regulatory submissions, HTA negotiations, label expansions, and post-authorization commitments, with the CEO Setareh A. Williams claiming over 25 years of pharma industry experience across AstraZeneca, Pfizer, Novartis, and Radius Health.

The firm's underlying technology stack is described as a combination of traditional analytics, statistical modeling, and artificial intelligence methodologies applied to diverse data sources — electronic health claims, pharmacy data, registries, and patient-reported outcomes — for evidence generation and reporting. No proprietary platform, software product, or API is offered; deliverables are consulting outputs (manuscripts, study reports, regulatory documents, scientific communication platforms) rather than licensed technology. Head of Data Science David J. Smith brings a Cambridge PhD plus MIT AI/ML certifications, signaling an intent to formalize AI-augmented RWE analytics.

Commercially, SBC operates on a project-based professional services model with quote-based, scope-driven pricing. No subscription, recurring retainer, or platform licensing revenue is disclosed. The firm uses peer-reviewed publications, LinkedIn thought leadership, webinars/podcasts, email newsletters, and ISPOR conference participation as its primary marketing channels, and sells exclusively through direct enterprise engagement. A reciprocal partnership with Mirador Global extends its access and commercial strategy offering. No external investors, funding rounds, named customer logos, or disclosed revenue figures appear in available sources.

Name

Star Biopharma Consulting

Legal name

Star Biopharma Consulting LLC

Website

https://starbiopharmaconsulting.com

Company type

Private

Founded year

1999

Operating status

Operating

Headcount range

1–10 employees

Short description

Star Biopharma Consulting is a privately held life sciences consultancy serving pharmaceutical, biotechnology, and medical device clients with real-world evidence generation, HEOR, medical affairs, scientific communications, patient-centered research, market access, and biopharma staffing services.

Ownership category

akta.pro rank

Product category

Pharmaceutical Consulting Services

NAICS

Management Consulting Services (54161), Other Scientific and Technical Consulting Services (54169)

SIC

Services-Management Consulting Services (8742)

akta.pro primary industry

Medical Affairs, Scientific Communications & HEOR FSP (HLAGAOAG)

akta.pro secondary industry

Life Sciences & Biotech (R&D/Clinical) Staffing (BPACADAL)

Keywords

• Real world evidence consulting
• Health economics outcomes research
• Medical affairs consulting
• Market access strategy
• Scientific communications services

Headquarters

HQ city

Philadelphia

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Marketing or Sales, Technology or R&D, Operations

Revenue model

1. Strategic Consulting Services: The company provides strategic consulting to pharmaceutical, biotech, and medical device companies for evidence generation, regulatory submission support, and market access. Services include real-world evidence studies, medical affairs support, scientific communications, patient-centered research, and staffing solutions.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Star Biopharma Consulting is a life sciences consulting firm that provides strategic consulting and execution services for pharmaceutical, biotech, and medical device companies in the planning, execution, and scientific communication of real-world evidence studies. The firm supports regulatory submissions, Health Technology Assessment negotiations, medical affairs, patient-centered research, market access, and product lifecycle management through six interconnected service lines spanning pre-launch through post-authorization.

Product overview

Star Biopharma Consulting is a consulting firm offering a portfolio of six interconnected service offerings focused on evidence generation and communication for the life sciences industry. The core service is Real World Evidence and Data Solutions, which supports regulatory submissions and market access through observational studies. This is complemented by Scientific Communications and Publications (medical writing and regulatory documentation), Medical Affairs strategy, Patient-Centered Research, Market Access Support, and Staffing and Recruitment services. Together, these services provide end-to-end support from pre-launch evidence planning through post-authorization commitments.

Differentiator

Problem solved

Functional benefit

Products and services

• Scientific Communications and Publications

Quantifiable outcome

• Over 50 peer-reviewed publications by CEO Setareh Williams alone, with 70+ additional publications by team member Russell Becker

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• Mirador GlobalminorStrategic or Co-development PartnerMirador Global partners with Star Biopharma Consulting to support clients who need Access and Commercial Strategy solutions. Fusun Sevgen, Head of Market Access at SBC, also serves as SVP at Mirador Global, indicating a collaborative relationship between the two consulting firms.

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Evidera: Evidera (a PPD/Thermo Fisher business) is a dedicated HEOR, real-world evidence, and market access consulting firm serving pharma and biotech. Directly comparable to SBC's RWE/HEOR/medical affairs/market access service mix at significantly greater scale.
• ZS Associates: ZS Associates operates a large life sciences practice delivering real-world evidence, HEOR, and commercial strategy consulting to pharma and biotech. Comparable to SBC across RWE and market access, with deeper commercial analytics scale.
• Avalere Health: Avalere Health is a healthcare consulting firm specializing in evidence generation, HEOR, market access, and policy advisory for life sciences clients. Direct competitor across SBC's core service lines with a similar boutique-but-established positioning.
• Cytel: Cytel provides statistical and HEOR/RWE consulting for pharmaceutical and biotech clients. Comparable to SBC in scientific rigor and therapeutic-area expertise, with deeper biostatistics and clinical trial analytics capabilities.
• Analysis Group: Analysis Group is a private consulting firm with a strong HEOR and real-world evidence practice serving pharma, biotech, and medical device clients. Direct competitor for HEOR/RWE engagements and patient-centered outcomes research.
• Trinity Life Sciences: Trinity Life Sciences provides strategic consulting, RWE, and medical affairs services to pharma and biotech. Overlaps with SBC's scientific communications, medical affairs, and market access offerings.
• Xcenda: Xcenda, part of Cencora (formerly AmerisourceBergen), provides HEOR, market access, and real-world evidence consulting to pharma manufacturers. Closely overlaps with SBC's market access and RWE offerings and serves the same pharma/biotech buyer.

Broad incumbents

• ICON plc: ICON plc (including PRA Health Sciences) is a global CRO with significant real-world evidence and HEOR capabilities post the PRA acquisition. Competes with SBC on RWE/HEOR work within a much larger clinical services portfolio.
• Parexel International: Parexel is a global CRO offering RWE, HEOR, market access, and regulatory consulting as part of its broader clinical development services. Overlaps with SBC's RWE and regulatory preparedness offerings.
• IQVIA: IQVIA is the largest CRO and life sciences analytics provider, with extensive RWE, HEOR, and medical affairs capabilities through dedicated practices. Represents the broad incumbent against which SBC competes for RWE/HEOR engagements.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/star-biopharma-consulting

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Star Biopharma Consulting